| Name | Antitumor agent-28 |
|---|
| Description | Antitumor agent-28 selectively inhibits ataxia telangiectasia mutated (ATM) kinase. Antitumor agent-28 prevents ATM mediated disease and has potent anti-cancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
ATM ATR |
| In Vitro | Antitumor agent-28 inhibits ataxia telangiectasia mutated (ATM; IC50=7.6 nM; HT29 cells), ataxia telangiectasia and Rad3-related protein (ATR; IC50=18 μM; HT29 cells), PI3Ka (IC50=0.24 μM; BT474 cells). Antitumor agent-28 does not inhibit mTOR in MDA-MB-468 cells[1]. |
| References |
| Molecular Formula | C25H32N6O4S |
|---|---|
| Molecular Weight | 512.62 |